Phase II of Naltrexone in Hormone-Refractory Metastatic Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: naltrexone|PROCEDURE: PET scan
Sponsor: Masonic Cancer Center, University of Minnesota